INS and metabolic syndrome: However, it is becoming increasingly evident that all cellular and biochemical alterations observed in metabolic syndrome such as impairment of endothelial cell function, abnormality in essential fatty acid metabolism and alterations in lipid mediators along with abnormal insulin/leptin signaling may represent a pathological bridge between metabolic syndrome and neurological disorders such as stroke.